Publications

Risk of adverse events with the addition of targeted agents to endocrine therapy in patients with hormone receptor-positive metastatic breast cancer: A systematic review and meta-analysis.
Cancer Treat Rev 2017 Oct 28. Epub 2017 Oct 28.
Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium; Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium. Electronic address:


Minimal Residual Disease Assessment Improves Prediction of Outcome in Patients With Chronic Lymphocytic Leukemia (CLL) Who Achieve Partial Response: Comprehensive Analysis of Two Phase III Studies of the German CLL Study Group.
J Clin Oncol 2016 Aug 29. Epub 2016 Aug 29.
Gabor Kovacs, Sandra Robrecht, Anna Maria Fink, Jasmin Bahlo, Paula Cramer, Julia von Tresckow, Christian Maurer, Petra Langerbeins, Kirsten Fischer, Michael Hallek, and Barbara Eichhorst, University of Cologne and Center of Integrated Oncology Cologne/Bonn, Cologne; Matthias Ritgen, Michael Kneba, and Sebastian Böttcher, University of Schleswig-Holstein, Lubeck; Hartmut Döhner and Stephan Stilgenbauer, University of Ulm, Ulm; Wolfram Klapper, University of Kiel, Kiel; Clemens-Martin Wendtner, Klinikum Schwabing, Munich, Germany; and Günter Fingerle-Rowson, F. Hoffmann La-Roche, Basel, Switzerland.



Long-term remissions after FCR chemoimmunotherapy in previously untreated patients with CLL: updated results of the CLL8 trial.
Blood 2016 Jan 20;127(2):208-15. Epub 2015 Oct 20.
Department I for Internal Medicine and Center of Integrated Oncology, University of Cologne, Cologne, Germany; Cluster of Excellence Cellular Stress Responses in Aging Associated Diseases, University of Cologne, Cologne, Germany.


Measuring lateral shuffle and side cut performance.
J Strength Cond Res 2013 Nov;27(11):3197-203
1Human Performance Laboratory, Faculty of Kinesiology, University of Calgary, Calgary, Canada; 2Faculty of Human Movement Sciences, VU University Amsterdam, Amsterdam, The Netherlands; and 3School of Health and Human Sciences, Southern Cross University, Lismore, New South Wales, Australia.

OF